Ascendis Health Limited (ASC.JO)

81.00 0.00 (0.00%) At close: 03:22PM SAST

Ascendis Health Limited

1 Carey Street
Wynberg
Sandton 2090
South Africa
27 11 036 9600
https://www.ascendishealth.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. A. Carl Neethling	CEO, Acting CFO & Director	81k	N/A	1980
Mr. Joseph Fine	Head of Legal & Company Secretary	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ZAc.

Description

Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Romania. It operates through Consumer Health, Pharma, and Medical Devices segments. The company offers natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Preg, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Solal, and Vitaforce brand names. It also provides medical devices, and diagnostic laboratory equipment and consumables under the Reuterina, Pharmachem, Sinucon, Phlexy, Clonam, Surgical Innovations, RCA, and The Scientific Group brands. It also exports its products. The company serves pharmacies, private hospitals, and doctors, as well as government. The company was incorporated in 2008 and is based in Sandton, South Africa.

Corporate Governance

Ascendis Health Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.